Fund: FTBDF

Franklin Templeton - Franklin Biotechnology Discovery Fund A(acc)USD - 4912
LU0109394709
03-04-2000
Equity
Equity Sectors - Health Care
Franklin Templeton Investment Funds
Franklin Advisers, Inc.
Evan McCulloch
USD
1,000
5.75%
 
EIC Fund Rating (2020)
Rok Rated portolio Ref. ccy Rating category Rf (p.a.) Rm (p.a.) Return (p.a.) Correlation Beta Alpha (p.a.) Rank Stars
2020 FTBDF USD EQ-SEC-HC 0.3675% 26.57% 38.12% 0.92 1.21 6.18% 3/8
2019 FTBDF USD EQ-SEC-HC 2.1319% 23.40% 35.60% 0.88 1.59 -0.45% 5/7
2018 FTBDF USD EQ-SEC-HC 1.8344% -6.34% -17.33% 0.82 1.41 -7.59% 7/8
2017 FTBDF USD EQ-SEC-HC 1.0263% 21.62% 18.79% 0.77 1.81 -19.55% 8/8
2016 FTBDF USD EQ-SEC-HC 0.3901% -9.83% -15.55% 0.77 1.69 1.31% 5/11
2015 FTBDF USD EQ-SEC-HC 0.1342% 11.89% 10.97% 0.77 1.53 -4.77% 8/11
2014 FTBDF USD EQ-SEC-HC 0.0923% 31.35% 59.54% 0.81 1.88 0.69% 5/11
41.3200
06-06-2024
-0.6014%
Quick compare
1M 3M 6M 9M 1R 3R p.a. 5R p.a. 7R p.a. 10R p.a. od vnizku p.a.
Výkonnosť fondu 0.90% -5.81% 21.42% 21.78% 21.85% 0.32% 6.87% 5.22% 5.46% N/A
Priemerná výkonnosť (36 meraní) 0.15% -2.79% 0.61% 3.28% 2.63%
Volatilita od priemernej výkonnosti 9.36% 29.76% 8.29% 6.15% 4.63%
Rozloženie aktív
Long Short Net
Stock 98.38% 98.38%
Bond
Other 0.58% 0.58%
Cash 1.94% 0.90% 1.04%
Veľkosť fondu
Aktíva13,653 mil.
Počet akcíí88
Počet dlhopisov1
Nákladovosť fondu
Priebež. popl.1.81
 z toho Mng. popl.1.50
Výk. prémia
Trans. popl.0.04
Výnosovosť fondu
Dividenda
Dividendový výnos
Rozhodný dátum
Frekvencia výplaty
Akciové portfólio
Giant 3.69%
Large 23.23%
Medium 15.87%
Small 20.53%
Micro 27.99%
P/E16.79%
P/BV4.06%
Sektorové rozloženie
Basic Materials 1.06%
Healthcare 94.96%
Dlhopisové portfólio
Corporate 0.58
Derivatives 1.04
Výnos do splatnosti p.a.
Modifikovaná durácia
Kreditné rozloženie
AAA 0.00
AA 76.61
A 0.00
BBB 0.00
BB 0.00
B 0.00
Below B 0.00
Not Rated 23.39
Regionálne rozloženie
United States 83.38%
Canada 1.02%
Latin America
United Kingdom 4.57%
Eurozone 4.03%
Europe - ex Euro 4.07%
Europe - Emerging
Africa
Middle East
Japan
Australasia
Asia - Developed
Asia - Emerging
Emerging Market
Developed Country 97.07%
Not Classified
Top 10 pozícií
SpoločnosťSubsektorVáha SpoločnosťSubsektorVáha
Amgen Inc Healthcare 7.08% Regeneron Pharmaceuticals Inc Healthcare 6.34%
Vertex Pharmaceuticals Inc Healthcare 5.39% Ascendis Pharma A/S ADR Healthcare 4.07%
AstraZeneca PLC ADR Healthcare 3.69% Biogen Inc Healthcare 3.15%
Gilead Sciences Inc Healthcare 2.99% Intra-Cellular Therapies Inc Healthcare 2.91%
Jazz Pharmaceuticals PLC Healthcare 2.69% Neurocrine Biosciences Inc Healthcare 2.64%